Monitoring post-translational modification of proteins with allosteric ribozymes

被引:46
作者
Vaish, NK
Dong, F
Andrews, L
Schweppe, RE
Ahn, NG
Blatt, L
Seiwert, SD
机构
[1] Ribozyme Pharmaceut Inc, Boulder, CO 80301 USA
[2] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词
D O I
10.1038/nbt719
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
An allosteric hammerhead ribozyme activated specifically by the unphosphorylated form of the protein kinase ERK2 was created through a rational design strategy that relies on molecular recognition of ERK2 to decrease the formation of an alternate, inactive ribozyme conformer. Neither closely related mitogen-activated protein kinases (MAPKs) nor the phosphorylated form of ERK2 induced ribozyme activity. The ribozyme quantitatively detected ERK2 added to mammalian cell lysates and also functioned quantitatively in a multiplexed solution-phase assay. This same strategy was used to construct a second ribozyme selectively activated by the phosphorylated (active) form of ERK2. This approach is generally applicable to the development of ribozymes capable of monitoring post-translational modification of specific proteins.
引用
收藏
页码:810 / 815
页数:6
相关论文
共 42 条
  • [41] Interaction of U2AF(65) RS region with pre-mRNA of branch point and promotion base pairing with U2 snRNA
    Valcarcel, J
    Gaur, RK
    Singh, R
    Green, MR
    [J]. SCIENCE, 1996, 273 (5282) : 1706 - 1709
  • [42] Selection, design, and characterization of a new potentially therapeutic ribozyme
    Zinnen, SP
    Domenico, K
    Wilson, M
    Dickinson, BA
    Beaudry, A
    Mokler, V
    Daniher, AT
    Burgin, A
    Beigelman, L
    [J]. RNA, 2002, 8 (02) : 214 - 228